Search

Search Results
Results 18641 - 18650 of 19058 for breast cancer
  • News - 29 Dec 2009
    Affomix Corporation, a pioneer in the development of automated, high-throughput monoclonal antibody selection technology, announced today that Kalgene Pharmaceuticals Inc. has signed a commercial...
  • News - 5 Oct 2008
    The health care proposal of Democratic presidential nominee Sen. Barack Obama (Ill.) is more likely to improve health care affordability, accessibility, efficiency and quality than the plan of...
  • News - 10 Jan 2006
    HHS Secretary Mike Leavitt has announced the awarding of $56.9 million by the National Institutes of Health’s (NIH) National Center on Minority Health and Health Disparities (NCMHD).
  • News - 28 Oct 2004
    New hormone therapy studies demonstrate estrogen's ability to directly stimulate neurons, repair damaged neurons, and stimulate support cells—most of which can alleviate some of the cognitive decline...
  • Drug - 14 May 2026
    Consumer Medicine Information (CMI) about Depo-Nisolone intended for persons living in Australia.
  • Drug - 14 May 2026
    Consumer Medicine Information (CMI) about Depo-Medrol intended for persons living in Australia.
  • Drug - 14 May 2026
    Consumer Medicine Information (CMI) about Braftovi intended for persons living in Australia.
  • Drug - 13 May 2026
    Consumer Medicine Information (CMI) about Saphnelo intended for persons living in Australia.
  • Drug - 13 May 2026
    Consumer Medicine Information (CMI) about Brukinsa intended for persons living in Australia.
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Solu-Medrol intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.